Результаты поиска

Dural Lymphomas Unmasked: A Narrative Review of Extra-Axial Mimics and a Pragmatic Diagnostic Decision Algorithm.

Dural-based lymphomas are rare extranodal non-Hodgkin lymphomas that span from indolent primary dural entities, most commonly the extranodal marginal zone (mucosa-associated lymphoid tissue) lymphoma, to aggressive variants that are primary or represent secondary involvement from systemic lymphoma. They overlap radiologically with benign meningiomas, dural metastases, and immune-mediated pachymeningitis, creating a risk of anchoring bias, delayed diagnosis, and unnecessarily extensive resections when limited tissue sampling would be sufficient for diagnosis. We conducted a structured narrative

Воздействие моделей перорального ухода на профилактику перорального слизистого слизняка, вызванного высокими дозами мельфалана у пациентов, страдающих АЦТ.

Высокодозированные мелфаланы (МЭЛ) в сочетании с аутологической трансплантацией стволовых клеток (ASCT) эффективно лечат множественные миеломы (MM), но часто вызывают оральный слизистой мукосит (OM), влияющий на исход пациента. Цель этого исследования заключается в оценке эффективности усовершенствованной модели орального ухода в деле предотвращения ОМ, вызванного МЭЛ. В этом ретроспективном исследовании были рассмотрены медицинские записи 87 больные с MM, которые прошли ACCT в первой родственной больнице Сокхоуского университета в декабре 2019 и февраль 2022. В соответствии с протоколами о пе

Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing.

T-cell redirecting therapies (TCR) marked a step forward in the treatment of relapsed/refractory multiple myeloma (RRMM). These agents, represented by chimeric antigen receptor (CAR) T-cells and bispecific antibodies (BsAbs), proved to ameliorate the prognosis of difficult-to-treat patients in pivotal clinical trials, leading to their introduction into clinical practice. Both strategies rely on recruiting patients' T-cells against specific tumor antigens, with B-cell maturation antigen (BCMA) and G-protein coupled receptor group C family 5 member D (GPRC5D) being the targets most extensively s

Qualitative and Quantitative Inter-Observer Agreement of Multiparametric Whole-Body MRI in Staging and Follow-Up of Myeloma Patients.

Background: Whole-body magnetic resonance imaging (WB-MRI) is incorporated into international guidelines and recommendations for imaging patients with multiple myeloma. The aim of this study was to investigate inter-observer agreement of radiologists with different levels of expertise in reporting whole-body MRI performed along MY-RADS criteria in myeloma at baseline and in evaluating response to therapy to better certify the use of these criteria. Methods: A total of 52 patients with symptomatic myeloma at first presentation (47) or relapse (5) and planned for a new line of therapy were inclu

Pharmacogenomics and Big Data in medical oncology: developments and challenges.

Medical oncology, through conventional chemotherapy as well as targeted drugs, remains an important component of cancer patient management, particularly for systemic disease. Despite advances in all areas of medical oncology, certain challenges persist in the form of drug resistance and severe normal tissue toxicity. These unwanted effects can be counteracted through a patient-tailored treatment approach, which in chemotherapy is translated as pharmacogenomics. This research field investigates the way genetic makeup influences a patient's response to various drugs with the aim to minimize tria

The Role of Post-Operative Radiotherapy for Non-Spine Bone Metastases (NSBMs).

Non-spine bone metastases (NSBMs) can cause significant morbidity and deterioration in the quality of life of cancer patients. This paper reviews the role of post-operative radiotherapy (PORT) in the management of NSBMs and provides suggestions for clinical practice based on the best available evidence. We identified six retrospective studies and several reviews that examined PORT for NSBMs. These studies suggest that PORT reduces local recurrence rates and provides effective pain relief. Based on the literature, PORT was typically delivered as 20 Gy in 5 fractions or 30 Gy in 10 fractions wit

Gut Microbiota Dysbiosis and Dietary Interventions in Non-Hodgkin B-Cell Lymphomas: Implications for Treatment Response.

Non-Hodgkin B-cell lymphomas are a heterogeneous group of lymphoid malignancies with variable biological behavior, clinical presentation and treatment response. While chemoimmunotherapy remains the cornerstone of their management, growing evidence implicates the gut microbiota as a critical modulator of both lymphomagenesis and therapeutic efficacy. Gut microbiota dysbiosis, characterized by reduced microbial diversity and pathogenic taxonomic shifts, has been observed also in newly diagnosed patients and not just after therapy. This microbial imbalance contributes to mucosal barrier disruptio

Необычный случай тромбоцитопенсии и ренального провала, возрождающего злодеяние - ассоциированная тромботическая микроангиопатия.

Тромботическая микроангиопатия (TMA) — процесс, характеризующийся тромбоцитопенией, микроангиопатичной гемолитической анемией и конечной травмой. ТМА, связанная с злоумышленностью, встречается редко и может быть похожа на первичные синдромы ТМА, особенно в тех случаях, когда преобладает почечная дисфункция, а периферийные мазки ограничены. Мы представляем случай биопсии, подтвержденной почечной ТМА, при установлении недавно диагностированной метастатической скучной клеточной карциномы (SCC) после значительной диагностической неопределенности. 59-летний мужчина с сахарным диабетом, зависящим от

Emerging role of low-frequency somatic mutations in cancer relapse: from early detection to precision oncology.

Somatic mutations with low variant allele frequencies offer a highly sensitive lens for detecting cancer relapse driven by diverse causes, including clonal evolution and therapy resistance. Advances in next-generation sequencing have enabled robust subclonal variant identification that typically fall below conventional detection limits, supporting a comprehensive understanding of individual molecular profiles that can lead to relapse. These low-level alterations frequently emerge before clinical or radiological relapse and can inform response-adaptive treatment decisions. This review integrate

Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.

Multiple Myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal plasma cells in the bone marrow, with drug resistance being a major cause of therapeutic failure. We established a carfilzomib-resistant derivative of the LP-1 MM cell line (LP-1/Cfz) and found that the transcription factor NF-E2 p45-related factor 2 (Nrf2; gene symbol NFE2L2) contributes to carfilzomib resistance. The mechanism of Nrf2 activation involved enhanced translation of Nrf2 as well as its positive regulator, the autophagy receptor sequestosome 1 (SQSTM1)/p62. The eukaryotic translation initiatio

Клиническая практика - доказательство удовлетворенности лечением умеренными и высокоэффективными лекарствами при множественном склерозе.

ВВЕДЕНИЕ: Как правило, выбор методов лечения лиц с множественным склерозом (PwMS) зависит от эффективности и безопасности. Вместе с тем, учитывая разнообразие наркотиков и различные пути управления, важно знать опыт и удовлетворение ПВМС. Результаты, о которых сообщают пациенты, помогают нам оптимизировать и улучшить соблюдение. МЕТОДЫ: Наша цель при проведении такого межсекторального, неинтервенционного исследования заключается в анализе результатов удовлетворенности с использованием вопросника по удовлетворенности лечением лекарственными препаратами (TSCM) в зависимости от умеренной или высо

Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment.

The transition of immunotherapy administration from intravenous infusion to subcutaneous (SC) administration of monoclonal antibody formulations for oncology patients has garnered significant interest. SC administration offers multiple benefits, including potential for at-home administration, enhanced patient compliance, reduced hospital congestion, lowered health care costs, and improved sustainability by reducing drug wastage and minimizing environmental impact. However, for many biologics, the shift to SC administration requires the development of high-concentration monoclonal antibody prod

Assessment tools for chemotherapy-induced peripheral neuropathy: a narrative review of clinician, patient-reported, and objective measures.

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy, affecting motor, sensory, and autonomic function. Accurate assessment is important during treatment, when CIPN may necessitate dose reductions or discontinuation, and after treatment, as chronic CIPN can greatly impact quality of life and safety in cancer survivorship. Measurement tools can include subjective measures, including clinician-based grading scales or patient-reported outcome measures (PROMs), and objective measures. This review aimed to summarize current CIPN assessment tools, hig

Совпадение в полном тексте источника
… Curr Oncol Rep . 2020 ; 22 : 50 . 10.1007/s11912-020-00903-0 32323068 8 Yeo F , Ng CC , Loh KWJ , et al Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy . …

Impact of marital status on survival in patients with follicular lymphoma.

Although marital status has been associated with survival in several cancers, evidence regarding its prognostic relevance in follicular lymphoma (FL), an indolent lymphoma characterized by prolonged survival, remains limited. In this population-based study using the SEER database, we identified 23,434 adult patients diagnosed with FL between 2013 and 2022. Propensity score matching was performed to balance baseline characteristics, and survival outcomes were assessed using Kaplan-Meier analysis and Cox proportional hazards models. In the overall cohort, unmarried patients were more likely to b

Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis.

BACKGROUND: Spinal fractures are a common source of morbidity in cancer patients. Balloon Kyphoplasty (BKP) is a minimally invasive procedure designed to stabilize fractures and correct vertebral deformities. We performed a meta-analysis to determine the efficacy and safety of BKP for spinal fractures in cancer patients. METHODS: We searched several electronic databases up to September 2008 and the reference lists of relevant publications for studies reporting on BKP in patients with spinal fractures secondary to osteolytic metastasis and multiple myeloma. Outcomes sought included pain relief

Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe.

PurposeTo provide real-world data on patient perceptions and experiences with subcutaneous (SC) versus intravenous (IV) daratumumab.Patients and methodsThis was a cross-sectional, mixed-method (qualitative/quantitative) survey conducted in France, Germany, Spain and the United Kingdom involving multiple myeloma (MM) patients who switched from IV to SC daratumumab in the last 12 months (qualitative phase) or 24 months (quantitative phase [26 months in the UK]) prior to enrollment in the study.ResultsNine patients (mean age 65 years) participated in the qualitative phase and 113 patients (mean a

Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma.

Bispecific antibodies (BsAbs) are artificially engineered antibodies that can bind simultaneously to the CD3 subunit within the T-cell receptor complex and an antigen on tumor cells, leading to T-cell activation and tumor cell killing. BsAbs against BCMA or GPRC5D have shown impressive clinical activity in heavily pretreated patients with relapsed/refractory multiple myeloma (RRMM), with some agents having already received regulatory approval after the third (by the European Medicines Agency, EMA) or fourth (by the Food and Drug Administration, FDA) line of therapy; the results of early-phase

CAR-NK cell therapy for hematological malignancies.

AbstractChimeric antigen receptor (CAR)-natural killer (NK) cells represent a novel cell therapy platform distinguished from CAR T cells by their more favorable safety profile, easier off-the-shelf allogeneic manufacturing and consequent scalability, and their innate cytotoxicity without needing previous sensitization. CAR-NK cells derived from a variety of sources have been used against hematologic malignancies in several clinical trials, showing significant therapeutic responses and efficacy without severe adverse effects. Limitations that are being addressed in CAR-NK cell therapy include c

Ожирение и риск эпидемических подстрекательских заболеваний: исследование реальных тенденций с использованием электронных медицинских записей.

Ожирение - это растущая глобальная проблема в области здравоохранения и хроническое подстрекательское состояние, которое может повлиять на иммунную терпимость и автоиммунитет. В то время как в предыдущих исследованиях рассматривались связи между ожирением и отдельными иммунизированными подстрекательскими заболеваниями (ИМИД), более широкое воздействие ожирения в широком спектре ИМИД остается неясным. Мы провели крупномасштабное когортное исследование с использованием глобальной электронной базы данных о состоянии здоровья населения TriNetX. Взрослые ≥ 18 годы с индексом массы тела (ИОВ) ≥ 18.5

Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem.

The Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has significantly impacted global health and healthcare delivery systems. To characterize the secondary effects of the COVID-19 pandemic and mitigation strategies used in the delivery of hematopoietic stem cell transplantation (HSCT) care, we performed a comprehensive literature search encompassing changes in specific donor collection, processing practices, patient outcomes, and patient-related concerns specific to HSCT and HSCT-related healthcare delivery. In this review,